查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403525

心臟衰竭POC和LOC設備的全球市場至2030年的預測：按測試類型、技術、最終用戶和地區進行分析

Heart Failure POC And LOC Devices Market Forecasts to 2030 - Global Analysis By Test Type, Technology, End User and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的資料，2023年全球心臟衰竭POC 和LOC設備市場規模為 9,762 萬美元，預計到2030年將達到 3.2794 億美元，預測期內年複合成長率為 18.9%。

稱為即時護理（POC）和晶片實驗室（LOC）的設備徹底改變心臟衰竭治療。這些攜帶式快速診斷技術使醫療保健提供者能夠進行現場測試，以快速了解患者的心臟健康狀況。POC設備包括手持式超音波診斷設備、攜帶式心臟生物標記分析儀和小型化晶片實驗室平台，可在患者床邊或初級保健環境中提供快速有效的診斷。

根據2018年 CDC 報告，每年約有 655,000 名美國死於心臟病，使其成為美國的主要原因（佔死亡人數的四分之一）。

心臟衰竭率上升

POC和LOC設備市場的主要促進因素是與人口老化、久坐生活方式和心血管危險因子負擔增加相關的心臟衰竭發病率上升。此外，心臟衰竭的盛行率在全球範圍內不斷增加，這增加了對能夠快速準確地評估心臟功能並支持快速有效的治療計劃的診斷儀器的需求。

預算限制和可及性

與POC和LOC設備相關的財務限制不僅包括初始採集費用，還包括消耗品、維護和校準等持續費用。此外，患者和醫療機構都擔心負擔能力，特別是在資源有限的環境中。這些先進的診斷工具初期成本較高，可能會阻礙廣泛採用、限制可近性並影響醫療保健服務的成本效益。

擴大診斷專業知識

POC和LOC儀器提供的診斷能力有很多提高的機會。持續的技術進步，特別是在生物感測器、微流體和奈米技術等領域，為提高此類設備的靈敏度和特異性提供了潛力。此外，多重測試的進步和新型生物標記的整合使醫療保健專業人員能夠對心血管健康有更深入、更全面的了解。

市場競爭激烈

POC及LOC設備市場競爭激烈，有定價壓力、市場飽和、產品差異化困難等風險。由於新進入者和持續的技術進步，競爭壓力日益增加。此外，為了保持競爭力，公司需要投資於研發，實施有效的行銷策略，並致力於開發獨特的價值提案，以保持其市場地位並持續成長。

COVID-19 的影響：

COVID-19 的爆發對醫療診斷市場產生了重大影響，尤其是 POC（照護端）和 LOC（晶片實驗室）設備。由於迫切需要快速和分散的測試解決方案，特別是對於 COVID-19 診斷，對 POC 和 LOC 設備的需求激增。這些技術進步對於提高檢測的可及性和促進在照護端快速獲得結果非常重要。另一方面，疫情也帶來了醫療資源配置變化、競爭加劇、供應鏈中斷等挑戰。此外，疫情的管理刺激了技術創新，凸顯了POC和LOC設備在靈活、去中心化的醫療保健系統中所發揮的關鍵作用，這似乎將影響疫情後市場的未來走向。

基因組測試領域預計將在預測期內成為最大的領域

預計在心臟衰竭POC 和 LOC 設備市場中佔據最大佔有率的是基因組測試。作為基因組測試的一部分，對人類的 DNA 進行分析以發現遺傳變異、突變和疾病傾向。該領域因其廣泛的應用而獲得認可，包括藥物基因組學、腫瘤學、罕見遺傳疾病和個人化醫療。基因組檢測對於疾病診斷、治療和風險評估非常重要。其結果是更專業和高效的醫療保健干預措施。此外，由於定序技術的不斷改進和對各種疾病遺傳原因的了解不斷增加，基因組測試變得越來越普及，並被認為是分子診斷領域的主要參與者。

預計家庭護理行業在預測期內的年複合成長率最高。

在心臟衰竭POC和LOC設備市場中，居家照護領域的年複合成長率最高。接受居家照護服務的患者在舒適的家中接受醫療照護、監督和支持。許多因素導致了居家照護需求的增加，包括人口老化、對個人化、以患者為中心的護理的渴望以及遠端監控技術的進步。除了為患者提供便利外，居家照護服務還可透過最大限度地減少住院次數來降低醫療成本。此外，隨著越來越多的人尋求危險較小的面對面護理替代方案，COVID-19 大流行加速了居家醫療服務的使用。

佔有率最大的地區

心臟衰竭POC和LOC設備市場預計將佔據北美地區的最大佔有率。這是由於高醫療支出、先進的醫療基礎設施、強大的監管基礎以及對研發的重視等因素所造成的。尤其美國，擁有蓬勃發展的醫療保健產業，這大幅促進了該地區的主導地位。此外，北美還受益於醫療保健、技術創新和對人口老化的關注的改善。

年複合成長率最高的地區：

亞太地區心臟衰竭POC和LOC設備市場的年複合成長率最高。醫療意識的提高，可支配收入增加，醫療基礎設施改善，老化和人口成長是推動這一爆炸性成長的一些因素。中國和印度等亞太國家對醫療保健服務和技術進行大量投資，並採取鼓勵性的政府措施。此外，對尖端醫療保健的需求和慢性病的增加也支撐著亞太醫療保健市場的強勁成長。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多3家公司）
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球心臟衰竭POC 和 LOC 設備市場：依測試類型

  • 蛋白質體學測試
  • 代謝組測試
  • 基因組測試
  • 其他測試類型

第6章 全球心臟衰竭POC 和 LOC 設備市場：依技術分類

  • 微流體學
  • 基於陣列的系統
  • 其他技術

第7章 全球心臟衰竭POC 和 LOC 設備市場：依最終用戶分類

  • 診所和醫院
  • 居家護理
  • 輔助醫療設施
  • 實驗室
  • 專業中心
  • 其他最終用戶

第8章 全球心臟衰竭POC 和 LOC 設備市場：依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • Instrumentation Laboratory Company
  • F. Hoffmann-La Roche Ltd
  • Abaxis, Inc.
  • Jant Pharmacal Corporation
  • Danaher Corporation
  • Siemens Healthineers
  • Trinity Biotech
  • Quidel Corporation
  • Abbott
  • bioMerieux SA
Product Code: SMRC24750

According to Stratistics MRC, the Global Heart Failure POC and LOC Devices Market is accounted for $97.62 million in 2023 and is expected to reach $327.94 million by 2030 growing at a CAGR of 18.9% during the forecast period. Devices known as point-of-care (POC) and lab-on-a-chip (LOC) have become revolutionary in the treatment of heart failure. Healthcare providers can perform on-the-spot testing with these portable, rapid diagnostic technologies, giving them quick insights into a patient's cardiac health. POC devices, which provide quick and effective diagnostics at the patient's bedside or in primary care settings, include handheld ultrasound devices, portable cardiac biomarker analyzers, and miniaturized lab-on-a-chip platforms.

According to a CDC report from 2018, approximately 655,000 Americans pass away from heart disease each year, making it the leading cause of death in the US (1 in every 4 deaths).

Market Dynamics:

Driver:

Growing heart failure rates

The market for POC and LOC devices is primarily driven by the rising incidence of heart failure, which is linked to aging populations, sedentary lifestyles, and the mounting burden of cardiovascular risk factors. Additionally, globally, the prevalence of heart failure is increasing, which raises the need for diagnostic instruments that can quickly and accurately evaluate cardiac function and support prompt and efficient treatment plans.

Restraint:

Budgetary restrictions and accessibility

The financial limitations pertaining to POC and LOC devices comprise not only the initial acquisition costs but also continuous expenditures like consumables, maintenance, and calibration. Furthermore, patients and healthcare facilities alike are concerned about affordability, especially in environments with limited resources. These advanced diagnostic tools come with a high upfront cost, which could prevent them from being widely adopted, restrict accessibility, and affect how cost-effectively healthcare is delivered.

Opportunity:

Extension of diagnostic expertise

There are numerous opportunities to increase the diagnostic capabilities that POC and LOC devices offer. Sustained technological progress, specifically in domains like biosensors, micro fluidics, and nanotechnology, offers prospects for augmenting the sensitivity and specificity of said apparatus. Moreover, healthcare practitioners can now obtain a deeper and more comprehensive understanding of cardiovascular health thanks to advancements in multiplexed testing and the integration of novel biomarkers.

Threat:

Strong market rivalry

The POC and LOC device market is highly competitive, which poses risks like price pressure, market saturation, and difficulty differentiating products. The pressure to compete is increased by new entrants and ongoing technological advancements. Furthermore, in order to stay competitive, businesses need to make investments in R&D, put effective marketing strategies into practice, and concentrate on developing distinctive value propositions in order to hold onto their market positions and continue growing.

COVID-19 Impact:

The COVID-19 pandemic has had a significant effect on the market for medical diagnostics, particularly point-of-care (POC) and lab-on-a-chip (LOC) devices. Demand for POC and LOC devices has surged due to the pressing need for quick and decentralized testing solutions, especially in the diagnosis of COVID-19. These technological advancements have been essential in improving test accessibility and facilitating prompt results at the point of care. On the other hand, the pandemic has also brought about difficulties like changes in the distribution of healthcare resources, heightened competition, and supply chain disruptions. Moreover, the management of the pandemic has spurred innovation and highlighted the critical role POC and LOC devices play in flexible, decentralized healthcare systems, which will impact the market's future direction in the aftermath of the pandemic.

The Genomic Testing segment is expected to be the largest during the forecast period

The segment of the heart failure POC and LOC devices market that is expected to hold the largest share is genomic testing. A person's DNA is analyzed as part of a genomic test to find genetic variants, mutations, and disease predispositions. The broad applications of this segment in pharmacogenomics, oncology, rare genetic disorders, and personalized medicine have made it more well-known. In order to diagnose, treat, and evaluate disease risk, genomic testing is essential. This results in more specialized and efficient healthcare interventions. Additionally, genomic testing is becoming increasingly popular and is becoming recognized as a major player in the field of molecular diagnostics due to the ongoing improvements in sequencing technologies and the growing knowledge of the genetic causes of various diseases.

The Home Care segment is expected to have the highest CAGR during the forecast period

In the market for heart failure POC and LOC devices, the home care segment is growing at the highest CAGR. Patients receiving home care services receive medical attention, supervision, and support in the comfort of their own homes. A number of factors, such as an aging population, a desire for individualized and patient-centered care, and developments in remote monitoring technologies, have contributed to the rise in demand for home care. In addition to providing patients with convenience, home care services lower healthcare costs by minimizing hospital stays. Moreover, the COVID-19 pandemic has expedited the uptake of home care services as individuals pursue less hazardous substitutes for in-person medical consultations.

Region with largest share:

It is projected that the heart failure POC and LOC device market will have the largest share in the North American region. This is ascribed to elements like high healthcare spending, sophisticated healthcare infrastructure, a solid regulatory base, and a strong emphasis on R&D. With a large healthcare industry footprint, the United States in particular is a major factor contributing to the region's dominance. Furthermore, North America gains from a focus on healthcare accessibility, technological innovation, and an aging population.

Region with highest CAGR:

The market for heart failure POC and LOC devices is growing at the highest CAGR in the Asia-Pacific region. Growing healthcare awareness, rising disposable incomes, growing healthcare infrastructure, and an aging and sizable population are some of the factors driving this explosive growth. Significant investments in healthcare services and technology are being made in APAC nations like China and India, along with encouraging government initiatives. Additionally, the demand for cutting-edge medical treatments and the rising incidence of chronic diseases both support the strong growth in the Asia-Pacific healthcare market.

Key players in the market:

Some of the key players in Heart Failure POC and LOC Devices market include Instrumentation Laboratory Company, F. Hoffmann-La Roche Ltd, Abaxis, Inc., Jant Pharmacal Corporation, Danaher Corporation, Siemens Healthineers, Trinity Biotech, Quidel Corporation, Abbott and bioMerieux S.A.

Key Developments:

In December 2023, Roche announced the entry into a definitive merger agreement to acquire Carmot Therapeutics, Inc., a privately owned US company based in Berkeley, California. Carmot's R&D portfolio includes clinical stage subcutaneous and oral incretins with best-in-class potential to treat obesity in patients with and without diabetes, as well as a number of preclinical programs.

In December 2023, Danaher Corp., a global life sciences and diagnostics provider based in Washington D.C., has completed its $5.7 billion acquisition of Abcam plc, a supplier of protein research tools for life sciences based in Cambridge, England. Abcam has become an indirect wholly owned subsidiary of Danaher. Danaher's Life Sciences businesses provide tools and technologies to support the advancement of pharmaceuticals and biopharmaceuticals.

In November 2023, Siemens Healthineers has secured a three-year, $5.5 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health, to develop a test to improve sepsis treatment.

Test Types Covered:

  • Proteomic Testing
  • Metabolomic Testing
  • Genomic Testing
  • Other Test Types

Technologies Covered:

  • Microfluidics
  • Array-based Systems
  • Other Technologies

End Users Covered:

  • Clinics & Hospitals
  • Home Care
  • Assisted Living Healthcare Facilities
  • Laboratory
  • Specialty Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Heart Failure POC And LOC Devices Market, By Test Type

  • 5.1 Introduction
  • 5.2 Proteomic Testing
  • 5.3 Metabolomic Testing
  • 5.4 Genomic Testing
  • 5.5 Other Test Types

6 Global Heart Failure POC And LOC Devices Market, By Technology

  • 6.1 Introduction
  • 6.2 Microfluidics
  • 6.3 Array-based Systems
  • 6.4 Other Technologies

7 Global Heart Failure POC And LOC Devices Market, By End User

  • 7.1 Introduction
  • 7.2 Clinics & Hospitals
  • 7.3 Home Care
  • 7.4 Assisted Living Healthcare Facilities
  • 7.5 Laboratory
  • 7.6 Specialty Centers
  • 7.7 Other End Users

8 Global Heart Failure POC And LOC Devices Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Instrumentation Laboratory Company
  • 10.2 F. Hoffmann-La Roche Ltd
  • 10.3 Abaxis, Inc.
  • 10.4 Jant Pharmacal Corporation
  • 10.5 Danaher Corporation
  • 10.6 Siemens Healthineers
  • 10.7 Trinity Biotech
  • 10.8 Quidel Corporation
  • 10.9 Abbott
  • 10.10 bioMerieux S.A

List of Tables

  • Table 1 Global Heart Failure POC And LOC Devices Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 3 Global Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
  • Table 4 Global Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
  • Table 5 Global Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
  • Table 6 Global Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 7 Global Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
  • Table 8 Global Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
  • Table 9 Global Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
  • Table 10 Global Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 11 Global Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 12 Global Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
  • Table 13 Global Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 14 Global Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
  • Table 15 Global Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 16 Global Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
  • Table 17 Global Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 18 North America Heart Failure POC And LOC Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 19 North America Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 20 North America Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
  • Table 21 North America Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
  • Table 22 North America Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
  • Table 23 North America Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 24 North America Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
  • Table 25 North America Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
  • Table 26 North America Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
  • Table 27 North America Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 28 North America Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 29 North America Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
  • Table 30 North America Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 31 North America Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
  • Table 32 North America Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 33 North America Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
  • Table 34 North America Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 35 Europe Heart Failure POC And LOC Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 36 Europe Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 37 Europe Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
  • Table 38 Europe Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
  • Table 39 Europe Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
  • Table 40 Europe Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 41 Europe Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
  • Table 42 Europe Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
  • Table 43 Europe Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
  • Table 44 Europe Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 45 Europe Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 46 Europe Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
  • Table 47 Europe Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 48 Europe Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
  • Table 49 Europe Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 50 Europe Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
  • Table 51 Europe Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 52 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 53 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 54 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
  • Table 55 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
  • Table 56 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
  • Table 57 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 58 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
  • Table 59 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
  • Table 60 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
  • Table 61 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 62 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 63 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
  • Table 64 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 65 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
  • Table 66 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 67 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
  • Table 68 Asia Pacific Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 69 South America Heart Failure POC And LOC Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 70 South America Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 71 South America Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
  • Table 72 South America Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
  • Table 73 South America Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
  • Table 74 South America Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 75 South America Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
  • Table 76 South America Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
  • Table 77 South America Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
  • Table 78 South America Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 79 South America Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 80 South America Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
  • Table 81 South America Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 82 South America Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
  • Table 83 South America Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 84 South America Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
  • Table 85 South America Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 86 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Country (2021-2030) ($MN)
  • Table 87 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 88 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Proteomic Testing (2021-2030) ($MN)
  • Table 89 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Metabolomic Testing (2021-2030) ($MN)
  • Table 90 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Genomic Testing (2021-2030) ($MN)
  • Table 91 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 92 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Technology (2021-2030) ($MN)
  • Table 93 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Microfluidics (2021-2030) ($MN)
  • Table 94 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Array-based Systems (2021-2030) ($MN)
  • Table 95 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 96 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 97 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Clinics & Hospitals (2021-2030) ($MN)
  • Table 98 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Home Care (2021-2030) ($MN)
  • Table 99 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Assisted Living Healthcare Facilities (2021-2030) ($MN)
  • Table 100 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Laboratory (2021-2030) ($MN)
  • Table 101 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Specialty Centers (2021-2030) ($MN)
  • Table 102 Middle East & Africa Heart Failure POC And LOC Devices Market Outlook, By Other End Users (2021-2030) ($MN)